Key Takeaways ABT received FDA approval for Volt PFA after a 392-patient study showed safety and effectiveness in AFib. The Volt PFA System combines mapping, pacing and ablation in one catheter using EnSite X 3D mapping. ABT's Volt PFA supports minimally invasive ablation with conscious sedation and reduced hemolysis. Abbott Laboratories (ABT) recently received FDA approval for its Volt PFA System to treat patients battling atrial fibrillation (AFib). The company is expected to begin commercial PFA cases in ...